SCHEMBL4098854

SCHEMBL4098854

N=C(N)Nc1cc(Cl)nc(N)n1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53
▸ KMT2A Q03164 4/20 0.46
▸ POLA1 P09884 1/20 0.46
▸ MAPT P10636 3/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ POLB P06746 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ HRH4 Q9H3N8 2/20 0.41
▸ HSP90AB1 P08238 5/20 0.39
▸ HSP90AA1 P07900 4/20 0.39
▸ KDM4E B2RXH2 2/20 0.37
▸ MEN1 O00255 1/20 0.34
▸ OPRM1 P35372 1/20 0.34
▸ OPRK1 P41145 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11020679 0.83 ATF1 (0.41) CYP2D6CYP2C19KMT2APOLA1
SCHEMBL11023223 0.81 CYP2D6 (0.34) CYP2D6CYP2C19KMT2A
SCHEMBL15942896 0.76 CYP2D6 (0.51) CYP2D6CYP2C19KMT2APOLA1MAPT
SCHEMBL10988809 0.75 MAPT (0.51) CYP2D6CYP2C19KMT2APOLA1MAPT
SCHEMBL7171477 0.74 CYP2D6 (0.56) CYP2D6CYP2C19KMT2APOLA1MAPT
SCHEMBL11022815 0.72 S1PR2 (0.38) CYP2D6CYP2C19KMT2A
SCHEMBL1576582 0.72 NUDT1 (0.55) CYP2D6CYP2C19KMT2APOLA1MAPT
SCHEMBL11018763 0.70 MAPT (0.41) CYP2D6CYP2C19KMT2AMAPTSMN1; SMN2
SCHEMBL3804329 0.70 HSP90AA1 (0.47) CYP2D6CYP2C19KMT2APOLA1MAPT
SCHEMBL11024801 0.70 NUDT1 (0.37) CYP2D6CYP2C19KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0062439-B1 GUANIDINOPYRIMIDINES SMITHKLINE BECKMAN CORPORATION (US) 1985-03-20 — — EP claimed
EP-0062439-A1 Guanidinopyrimidines SMITHKLINE BECKMAN CORPORATION (US) 1982-10-13 — — EP claimed
US-4336254-A Guanidinopyrimidine compounds, compositions and method of using as a diuretic SMITHKLINE CORPORATION (US) 1982-06-22 — — US claimed
US-20090194124-A1 Hair Shaping Kit and Process Comprising at Least One Non-Hydroxide Imine MALLE GERARD 2009-08-06 — — US disclosed
US-20090139537-A1 HAIR RELAXING COMPOSITION COMPRISING AT LEAST ONE NON-HYDROXIDE IMINE L'OREAL S.A. 2009-06-04 — — US disclosed
US-20050136017-A1 Cosmetic containing an imine reactive with the cystines of keratin fibers via a beta-elimination reaction to produce dehydroalanine and lead to formation of lanthionine in a medium free of polyhydroxylated alkane; guanidine and/or amidine imines such as dimethylguanidine; noncaustic for use on hair, skin L'OREAL S.A. (FR) 2005-06-23 — — US disclosed
US-20050129645-A1 Hair shaping composition comprising at least one non-hydroxide imine L'OREAL 2005-06-16 — — US disclosed
EP-1532963-A1 Composition for straightening the hair comprising at least one imine not being an hydroxide L'OREAL (FR) 2005-05-25 — — EP disclosed
EP-1532960-A1 Hair styling composition containing a non-hydroxide imine L'OREAL (FR) 2005-05-25 — — EP disclosed
EP-0062439-B1 GUANIDINOPYRIMIDINES SMITHKLINE BECKMAN CORPORATION (US) 1985-03-20 — — EP disclosed
EP-0062439-A1 Guanidinopyrimidines SMITHKLINE BECKMAN CORPORATION (US) 1982-10-13 — — EP disclosed
US-4336254-A Guanidinopyrimidine compounds, compositions and method of using as a diuretic SMITHKLINE CORPORATION (US) 1982-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090139537-A1 HAIR RELAXING COMPOSITION COMPRISING AT LEAST ONE NON-HYDROXIDE IMINE KRT18, INMT, INHA CYP2D6 3528/4885CYP2C19 2598/4885KMT2A 322/4885
US-20090194124-A1 Hair Shaping Kit and Process Comprising at Least One Non-Hydroxide Imine KRT18, KIT, PRDM7 CYP2D6 3530/4885CYP2C19 2140/4885KMT2A 555/4885
US-20050129645-A1 Hair shaping composition comprising at least one non-hydroxide imine KRT18, INHA, H1-5 CYP2D6 3645/4885CYP2C19 2413/4885KMT2A 949/4885
US-20050136017-A1 Cosmetic containing an imine reactive with the cystines of keratin fibers via a beta-elimination reaction to produce dehydroalanine and lead to formation of lanthionine in a medium free of polyhydroxylated alkane; guanidine and/or amidine imines such as dimethylguanidine; noncaustic for use on hair, skin BHMT, KRT18, INMT CYP2D6 2901/4885CYP2C19 2856/4885KMT2A 665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback